Also trades as: SIGHT.PA (PAR) · $vol 0M
GSGTF OTC
GenSight Biologics S.A.
1W: -11.1%
1M: -11.1%
3M: -11.1%
YTD: -57.9%
1Y: -57.9%
3Y: -97.5%
5Y: -98.9%
$0.08
-0.01 (-11.11%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$9M
+29.1% ▲
Capital Expenditures
$9M
+916756.4% ▲
5Y CAGR: +333.3%
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$243K
-26.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$29M | -$28M | -$26M | -$14M | -$12M |
| Depreciation & Amort. | $928K | $1M | $2M | $1M | $465K |
| Stock-Based Comp. | $5M | -$3M | $587K | $784K | $0 |
| Change in Working Capital | $5M | -$4M | $2M | $873K | $994K |
| Other Non-Cash Items | $858K | $91K | -$4M | -$2M | $1M |
| Operating Cash Flow | -$17M | -$34M | -$25M | -$13M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | -$32K | -$252K | -$10K | -$1K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $16K | $424K | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $219K | $18K | $180K |
| Investing Cash Flow | -$16K | $172K | $209K | $17K | $180K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4M | $3M | $13M | -$2M | $0 |
| Stock Repurchased | -$305K | -$193K | -$99K | -$27K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $28M | -$3M | -$1M | -$1M | $9M |
| Financing Cash Flow | $24M | $95K | $16M | $14M | $9M |
| Net Change in Cash | $6M | -$34M | -$8M | $330K | $243K |
| Cash End of Period | $44M | $11M | $2M | $2M | $2M |
| Free Cash Flow | -$17M | -$34M | -$25M | -$13M | $0 |